Last update 07 Apr 2025

LOX-22783

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PI3K Selective (Eli Lilly), LOX 22783, LOX-22783
+ [6]
Action
inhibitors
Mechanism
PIK3CA H1047R inhibitors(PIK3CA H1047R inhibitors)
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PIK3CA mutant Breast CancerPhase 1
China
27 Nov 2023
Advanced breast cancerPhase 1
United States
11 May 2022
Advanced breast cancerPhase 1
China
11 May 2022
Advanced breast cancerPhase 1
Japan
11 May 2022
Advanced breast cancerPhase 1
Australia
11 May 2022
Advanced breast cancerPhase 1
Belgium
11 May 2022
Advanced breast cancerPhase 1
Canada
11 May 2022
Advanced breast cancerPhase 1
France
11 May 2022
Advanced breast cancerPhase 1
Germany
11 May 2022
Advanced breast cancerPhase 1
Italy
11 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
PIK3CA mutant Breast Cancer
ESR1 D538G | H1047R/D350G
-
fwslsqmrjj(drynvaligz) = tvuhleakph ccixplnkxr (eznchwutll )
Positive
01 Mar 2023
fwslsqmrjj(drynvaligz) = vmhdgdgdhh ccixplnkxr (eznchwutll )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free